Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana

被引:25
作者
Abuaku, Benjamin [1 ]
Duah, Nancy [1 ]
Quaye, Lydia [1 ]
Quashie, Neils [1 ,2 ]
Koram, Kwadwo [1 ]
机构
[1] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Ghana
[2] Univ Ghana, Sch Med, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana
关键词
Therapeutic efficacy; Artemether-lumefantrine; Uncomplicated malaria; Ecological zones; Ghana; PLASMODIUM-FALCIPARUM MALARIA; ARTESUNATE PLUS AMODIAQUINE; RANDOMIZED-TRIAL; PARASITE CLEARANCE; SAFETY; PYRIMETHAMINE; COARTEM(R); NIGERIA; DELAY;
D O I
10.1186/1475-2875-11-388
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: In 2008, artemether - lumefantrine (AL) and dihydroartemisinin - piperaquine (DHAP) were added to artesunate - amodiaquine (AS-AQ) as first-line drugs for uncomplicated malaria in Ghana. The introduction of new drugs calls for continuous monitoring of these drugs to provide timely information on trends of their efficacy and safety to enhance timely evidence-based decision making by the National Malaria Control Programme. In this regard, the therapeutic efficacy of AL was monitored from September 2010 to April 2011 in four sentinel sites representing the three main ecological zones of the country. Methods: The study was a one-arm prospective evaluation of clinical and parasitological responses to directly observed treatment for uncomplicated malaria among children aged 6 months to 59 months using the 2009 WHO protocol for surveillance of anti-malarial drug efficacy. Children recruited into the study received weight-based 20/120 mg AL at 0, 8, 24, 36, 48, and 60 hrs. Parasitaemia levels were assessed on days 2, 3, 7, 14, 21, 28, and at any time a study child was brought to the clinic with fever. Results: A total of 175 children were enrolled into the study: 56 in the savanna zone, 78 in the forest zone and 41 in the coastal zone. Per-protocol analysis showed that the overall PCR-corrected cure rates on day 14 and day 28 were 96.5% (95% CI: 92.1, 98.6) and 95.4% (95% CI: 90.3, 98.0), respectively, with statistically significant differences between the ecological zones. The 90.4% day-28 cure rate observed in the savannah zone (95% CI: 78.2, 96.4) was significantly the lowest compared with 100% (95% CI: 93.2, 99.9) in the forest zone and 93.8% (95% CI: 77.8, 98.9) in the coastal zone (P = 0.017). Fever and parasite clearance were slower among children enrolled in the savannah zone. Gametocytaemia after day-3 post-treatment was rare in all the zones. Conclusions: The study has shown that AL remains efficacious in Ghana with significant ecologic zonal differences. The savannah zone may be a potential zone for any emergence of resistant alleles as a result of the slower parasite clearance observed in the zone.
引用
收藏
页数:8
相关论文
共 29 条
[1]   Malaria transmission in two rural communities in the forest zone of Ghana [J].
Abonuusum, Ayimbire ;
Owusu-Daako, Kofi ;
Tannich, Egbert ;
May, Juergen ;
Garms, Rolf ;
Kruppa, Thomas .
PARASITOLOGY RESEARCH, 2011, 108 (06) :1465-1471
[2]   Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up [J].
Adjei, George O. ;
Kurzhals, Jorgen A. L. ;
Rodrigues, Onike P. ;
Alifrangis, Michael ;
Hoegberg, Lotte C. G. ;
Kitcher, Emmanuel D. ;
Badoe, Ebenezer V. ;
Lamptey, Roberta ;
Goka, Bamenla Q. .
MALARIA JOURNAL, 2008, 7 (1)
[3]  
[Anonymous], DURAT MAL TRANSM SEA
[4]  
[Anonymous], 2002, MON ANT DRUG RES REP
[5]  
[Anonymous], 1991, MAL POP HOUS CENS 19
[6]  
[Anonymous], 2009, GUID CAS MAN MAL GHA
[7]   Benefits of using multiple first-line therapies against malaria [J].
Boni, Maciej F. ;
Smith, David L. ;
Laxminarayan, Ramanan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (37) :14216-14227
[8]   High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria [J].
Falade, C. O. ;
Ogundele, A. O. ;
Yusuf, B. O. ;
Ademowo, O. G. ;
Ladipo, S. M. .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2008, 13 (05) :635-643
[9]   A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda [J].
Fanello, C. I. ;
Karema, C. ;
van Doren, W. ;
van Overmeir, Chantal ;
Ngamije, D. ;
D'Alessandro, U. .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2007, 101 (04) :344-350
[10]   Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania [J].
Farnert, Anna ;
Ursing, Johan ;
Tolfvenstam, Thomas ;
Rono, Josea ;
Karlsson, Lillemor ;
Sparrelid, Elda ;
Lindegardh, Niklas .
MALARIA JOURNAL, 2012, 11